Keratoderma climactericum

From WikiMD's WELLNESSPEDIA

(Redirected from Haxthausen's disease)


Keratoderma climactericum
Synonyms Haxthausen's disease
Pronounce N/A
Specialty Dermatology
Symptoms Thickening of the palms and soles
Complications N/A
Onset Menopause
Duration Chronic
Types N/A
Causes Hormonal changes
Risks Postmenopausal women
Diagnosis Clinical examination
Differential diagnosis Palmoplantar keratoderma, Psoriasis
Prevention N/A
Treatment Emollients, Keratolytics, Topical corticosteroids
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Keratoderma climactericum is a rare, acquired, non-familial skin disorder that is characterized by the thickening of the skin on the palms of the hands and soles of the feet. It is most commonly seen in postmenopausal women and is often associated with hot flashes and sweating. The condition was first described by Haxthausen in 1901.

Symptoms and signs[edit]

The main symptom of keratoderma climactericum is the thickening of the skin on the palms and soles. This can lead to discomfort and pain, especially when walking or using the hands. Other symptoms can include redness, itching, and peeling of the skin. In some cases, the nails can also be affected, leading to nail dystrophy.

Causes[edit]

The exact cause of keratoderma climactericum is unknown. However, it is thought to be related to hormonal changes that occur during menopause. Some researchers believe that the condition may be triggered by a decrease in estrogen levels, which can affect the skin's ability to retain moisture.

Diagnosis[edit]

Diagnosis of keratoderma climactericum is usually based on the patient's symptoms and a physical examination of the skin. In some cases, a skin biopsy may be performed to confirm the diagnosis and rule out other conditions.

Treatment[edit]

Treatment for keratoderma climactericum typically involves the use of topical creams and ointments to help soften the skin and relieve symptoms. In severe cases, oral retinoids may be prescribed. In addition, patients are often advised to avoid activities that can exacerbate the condition, such as walking barefoot or using harsh soaps.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.